The Role of 18F-FDG PET/CT Imaging in Cancer Diagnosis and Management
Author Information
Author(s): Ahmad Almuhaideb, Nikolaos Papathanasiou, Jamshed Bomanji
Primary Institution: Institute of Nuclear Medicine, University College London Hospitals NHS Trust
Hypothesis
18F-FDG PET/CT is a valuable imaging tool for the detection and management of various cancers.
Conclusion
18F-FDG PET/CT significantly improves the accuracy of cancer diagnosis and management, changing treatment plans in a notable percentage of patients.
Supporting Evidence
- 18F-FDG PET/CT has become an important imaging tool in routine clinical oncology.
- It changes the management course in about 27% of patients.
- 18F-FDG PET/CT is particularly useful for detecting recurrence in asymptomatic patients with rising tumor marker levels.
- The sensitivity and specificity of 18F-FDG PET/CT vary across different cancer types.
Takeaway
This study shows that a special type of scan called 18F-FDG PET/CT helps doctors find and treat cancer better, sometimes changing how they decide to help patients.
Methodology
The review included published randomized controlled trials and systematic reviews, along with unpublished systematic reviews, focusing on the clinical usefulness of 18F-FDG PET/CT in oncology.
Limitations
The study notes limitations regarding the specificity of 18F-FDG uptake and variable avidity of some cancers for this tracer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website